The Jamaica Medical Cannabis Corporation Ltd. (JMCC), a Canadian-Jamaican medical cannabis exporter, signed an agreement to invest $2 million USD over ten years to identify analyze, and preserve Jamaica’s indigenous cannabis strains.

JMCC signed an official Memorandum of Agreement with the National Foundation for the Development of Science and Technology (NFDST) on Monday, June 25th, to undertake the project, titled “Identification, Isolation and Conservation of Local Strains of Cannabis for Medicinal Use.” The project is funded through the JMCC’s charitable foundation, 102.

“JMCC is fully committed to supporting the Jamaican medical cannabis industry every way we can and ensuring there are lasting benefits for the country and its people,” said Diane Scott, JMCC’s Chief Executive Officer. “As Jamaican medical cannabis grows in popularity, there is a real threat that the country’s unique strains will be lost or irrevocably contaminated by hybridization, and it was important for us to be able to help to preserve what we believe are some of the best medical cannabis strains in the world.”

– Read the entire article at Forbes.